Kovack Advisors’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Kovack Advisors's ROIV Position: Q3 2026 in Review
Kovack Advisors opened a new position in Roivant Sciences (ROIV) in Q3 2026: 1,293 shares worth $47.3K. The stake represents ﹤0.01% of the portfolio and ranks #1078 among its holdings.
521 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Kovack Advisors held 1,293 shares of Roivant Sciences worth $47.3K as of Q3 2026.
- Roivant Sciences was a new Kovack Advisors position in Q3 2026.
- Roivant Sciences made up ﹤0.01% of Kovack Advisors's portfolio in Q3 2026, its #1078 holding.
- 521 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Kovack Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.